LEPTOMENINGEAL METASTASIS
Clinical trials for LEPTOMENINGEAL METASTASIS explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL METASTASIS trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients with brain-spread disease
Disease control Not yet recruitingThis phase 2 trial tests a combination of the drug zorifertinib plus chemotherapy delivered directly into the fluid around the brain and spine. It is for people with a specific type of lung cancer (NSCLC with EGFR mutation) whose cancer has spread to the lining of the brain and s…
Matched conditions: LEPTOMENINGEAL METASTASIS
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug targets breast cancer in the brain
Disease control Not yet recruitingThis study tests a drug called SHR-A1811 in 51 women with HER2-positive breast cancer that has spread to the brain or the lining of the brain and spinal cord. The drug is given either through a vein or directly into the spinal fluid. The goal is to see if it is safe and can shrin…
Matched conditions: LEPTOMENINGEAL METASTASIS
Phase: PHASE1, PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC